Jeng Yow-Jiun, Watson Cheryl S
Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA.
BMC Cancer. 2009 Sep 18;9:334. doi: 10.1186/1471-2407-9-334.
Phytoestogens are a group of lipophillic plant compounds that can have estrogenic effects in animals; both tumorigenic and anti-tumorigenic effects have been reported. Prolactin-secreting adenomas are the most prevalent form of pituitary tumors in humans and have been linked to estrogen exposures. We examined the proliferative effects of phytoestrogens on a rat pituitary tumor cell line, GH3/B6/F10, originally subcloned from GH3 cells based on its ability to express high levels of the membrane estrogen receptor-alpha.
We measured the proliferative effects of these phytoestrogens using crystal violet staining, the activation of several mitogen-activated protein kinases (MAPKs) and their downstream targets via a quantitative plate immunoassay, and caspase enzymatic activities.
Four phytoestrogens (coumestrol, daidzein, genistein, and trans-resveratrol) were studied over wide concentration ranges. Except trans-resveratrol, all phytoestrogens increased GH3/B6/F10 cell proliferation at some concentration relevant to dietary levels. All four phytoestrogens attenuated the proliferative effects of estradiol when administered simultaneously. All phytoestrogens elicited MAPK and downstream target activations, but with time course patterns that often differed from that of estradiol and each other. Using selective antagonists, we determined that MAPKs play a role in the ability of these phytoestrogens to elicit these responses. In addition, except for trans-resveratrol, a serum removal-induced extrinsic apoptotic pathway was blocked by these phytoestrogens.
Phytoestrogens can block physiological estrogen-induced tumor cell growth in vitro and can also stimulate growth at high dietary concentrations in the absence of endogenous estrogens; these actions are correlated with slightly different signaling response patterns. Consumption of these compounds should be considered in strategies to control endocrine tumor cell growth, such as in the pituitary.
植物雌激素是一类亲脂性植物化合物,可在动物体内产生雌激素效应;已有关于其致癌和抗癌作用的报道。分泌催乳素的腺瘤是人类垂体肿瘤最常见的形式,且与雌激素暴露有关。我们研究了植物雌激素对大鼠垂体肿瘤细胞系GH3/B6/F10的增殖作用,该细胞系最初是基于其表达高水平膜雌激素受体α的能力从GH3细胞亚克隆而来。
我们使用结晶紫染色、通过定量板免疫测定法检测几种丝裂原活化蛋白激酶(MAPK)及其下游靶点的激活情况以及半胱天冬酶酶活性,来测量这些植物雌激素的增殖作用。
在较宽的浓度范围内研究了四种植物雌激素(香豆雌酚、大豆苷元、染料木黄酮和反式白藜芦醇)。除反式白藜芦醇外,所有植物雌激素在与饮食水平相关的某些浓度下均增加了GH3/B6/F10细胞的增殖。当同时给药时,所有四种植物雌激素均减弱了雌二醇的增殖作用。所有植物雌激素均引发了MAPK及其下游靶点的激活,但时间进程模式通常与雌二醇不同,且彼此之间也不同。使用选择性拮抗剂,我们确定MAPK在这些植物雌激素引发这些反应的能力中发挥作用。此外,除反式白藜芦醇外,这些植物雌激素阻断了血清去除诱导的外源性凋亡途径。
植物雌激素在体外可阻断生理性雌激素诱导的肿瘤细胞生长,在缺乏内源性雌激素的情况下,高饮食浓度时也可刺激生长;这些作用与略有不同的信号反应模式相关。在控制内分泌肿瘤细胞生长的策略中,如垂体肿瘤,应考虑摄入这些化合物。